Microbubbles 	Microbubbles 	 NNP	B-NP
:  	:  	 :	O
current  	current  	 JJ	O
state  	state  	 NN	O
and  	and  	 CC	O
future  	future  	 JJ	O
prospects  	prospects  	 NNS	O
Contrast-enhanced  	Contrast-enhanced  	 JJ	B-NP
ultrasound  	ultrasound  	 NN	I-NP
( 	( 	 -LRB-	O
CEUS 	CEUS 	 NNP	B-NP
)  	)  	 -RRB-	O
represents  	represents  	 VBZ	O
one  	one  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
most  	most  	 RBS	O
interesting  	interesting  	 JJ	O
applications  	applications  	 NNS	B-NP
of  	of  	 IN	O
traditional  	traditional  	 JJ	O
medical  	medical  	 JJ	B-NP
sonography 	sonography 	 NN	I-NP
.  	.  	 .	O
Ultrasound  	Ultrasound  	 JJ	B-NP
contrast  	contrast  	 NN	I-NP
agents  	agents  	 NNS	I-NP
are  	are  	 VBP	O
classified  	classified  	 VBN	O
into  	into  	 IN	O
first-  	first-  	 JJ	O
and  	and  	 CC	O
second-generation  	second-generation  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
depending  	depending  	 VBG	O
on  	on  	 IN	O
the  	the  	 DT	O
gas  	gas  	 NN	O
( 	( 	 -LRB-	O
nitrogen 	nitrogen 	 UH	B-NP
,  	,  	 ,	O
perfluorocarbon  	perfluorocarbon  	 NN	B-NP
or  	or  	 CC	O
sulfur  	sulfur  	 JJ	B-NP
hexafluoride 	hexafluoride 	 NN	I-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
the  	the  	 DT	O
microbubbles 	microbubbles 	 NN	B-NP
.  	.  	 .	O
Both  	Both  	 DT	O
generations  	generations  	 NNS	O
are  	are  	 VBP	O
characterized  	characterized  	 VBN	O
by  	by  	 IN	O
an  	an  	 DT	O
excellent  	excellent  	 JJ	O
safety  	safety  	 NN	O
profile 	profile 	 NN	O
,  	,  	 ,	O
with  	with  	 IN	O
low  	low  	 JJ	O
hepatic  	hepatic  	 NN	B-NP
and  	and  	 CC	O
renal  	renal  	 JJ	B-NP
toxicity  	toxicity  	 NN	I-NP
and  	and  	 CC	O
rare  	rare  	 JJ	O
central  	central  	 JJ	O
nervous  	nervous  	 JJ	O
system  	system  	 NN	B-NP
reactions 	reactions 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
respiratory  	respiratory  	 NN	B-NP
and  	and  	 CC	O
hepatic  	hepatic  	 JJ	B-NP
elimination  	elimination  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
gases  	gases  	 NN	O
explains  	explains  	 VBZ	O
the  	the  	 DT	O
low  	low  	 JJ	O
nephrotoxicity 	nephrotoxicity 	 NN	B-NP
.  	.  	 .	O
CEUS  	CEUS  	 NNP	B-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
successfully  	successfully  	 RB	O
employed  	employed  	 VBN	O
in  	in  	 IN	O
drug  	drug  	 NN	O
and  	and  	 CC	O
gene  	gene  	 NN	B-NP
delivery 	delivery 	 NN	I-NP
.  	.  	 .	O
Indeed 	Indeed 	 RB	O
,  	,  	 ,	O
new  	new  	 JJ	O
molecules  	molecules  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
liposomes 	liposomes 	 NN	B-NP
,  	,  	 ,	O
micelles  	micelles  	 NN	B-NP
and  	and  	 CC	O
perfluorocarbon  	perfluorocarbon  	 JJ	B-NP
nanoparticles  	nanoparticles  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
recently  	recently  	 RB	O
proposed  	proposed  	 VBN	O
as  	as  	 IN	O
ultrasound  	ultrasound  	 JJ	B-NP
contrast  	contrast  	 NN	I-NP
agents 	agents 	 NNS	I-NP
.  	.  	 .	O
Possible  	Possible  	 JJ	B-NP
future  	future  	 JJ	I-NP
applications  	applications  	 NNS	I-NP
of  	of  	 IN	I-NP
liposomes  	liposomes  	 NNS	I-NP
are  	are  	 VBP	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
hypertension  	hypertension  	 JJ	B-NP
complications  	complications  	 NNS	I-NP
( 	( 	 -LRB-	O
given  	given  	 VBN	O
the  	the  	 DT	O
possibility  	possibility  	 NN	O
to  	to  	 TO	O
fill  	fill  	 VB	O
them  	them  	 PRP	O
with  	with  	 IN	O
nitric  	nitric  	 JJ	B-NP
oxide 	oxide 	 NN	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
cerebral  	cerebral  	 JJ	B-NP
disease  	disease  	 NN	I-NP
with  	with  	 IN	O
xenon 	xenon 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
breast  	breast  	 NN	O
and  	and  	 CC	O
liver  	liver  	 JJ	O
cancer  	cancer  	 NN	O
with  	with  	 IN	O
doxorubicin 	doxorubicin 	 NN	B-NP
.  	.  	 .	O
Micelles  	Micelles  	 NNS	B-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
demonstrated  	demonstrated  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
effective  	effective  	 JJ	O
in  	in  	 IN	O
cancer  	cancer  	 NN	B-NP
treatment  	treatment  	 NN	I-NP
as  	as  	 IN	O
well 	well 	 RB	O
.  	.  	 .	O
Finally 	Finally 	 RB	O
,  	,  	 ,	O
perfluorocarbon  	perfluorocarbon  	 JJ	B-NP
nanoparticles  	nanoparticles  	 NN	I-NP
can  	can  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
in  	in  	 IN	O
oncological  	oncological  	 JJ	B-NP
settings  	settings  	 NNS	I-NP
and  	and  	 CC	O
in  	in  	 IN	O
pancreatic  	pancreatic  	 JJ	B-NP
islet  	islet  	 JJ	I-NP
transplantation  	transplantation  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
type  	type  	 NN	O
I  	I  	 PRP	O
diabetes 	diabetes 	 VBD	O
.  	.  	 .	O
